EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
40.640 |
Evidence |
|
EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
40.640 |
Evidence |
|
DAB1 |
DAB1: Disabled homolog 1 |
ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
40.640 |
Evidence |
|
ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
ARHGAP12 |
ARHGAP12: Rho GTPase-activating protein 12 |
40.640 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
40.550 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
40.550 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
40.550 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
40.550 |
Evidence |
|
RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
40.550 |
Evidence |
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
40.550 |
Evidence |
|
C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
40.550 |
Evidence |
|
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
40.550 |
Evidence |
|
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
SYK |
SYK: Tyrosine-protein kinase SYK |
40.550 |
Evidence |
|
CSDA |
CSDA, DBPA: DNA-binding protein A |
FXR2 |
FXR2, FMR1L2: Fragile X mental retardation syndrome-related protein 2 |
40.530 |
Evidence |
|
FGA |
IPI00021885 |
TNC |
TNC, HXB: Tenascin precursor |
40.530 |
Evidence |
|
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
STK4 |
STK4, MST1: Serine/threonine-protein kinase 4 |
40.530 |
Evidence |
|
PLD2 |
PLD2: Phospholipase D2 |
PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
40.530 |
Evidence |
|
PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
40.530 |
Evidence |
|
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
40.530 |
Evidence |
|
EPB41L2 |
EPB41L2: Band 4.1-like protein 2 |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
40.530 |
Evidence |
|
PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
40.530 |
Evidence |
|
FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
40.530 |
Evidence |
|
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
40.530 |
Evidence |
|
FGA |
IPI00021885 |
HAPLN1 |
HAPLN1, CRTL1: Hyaluronan and proteoglycan link protein 1 precursor |
40.530 |
Evidence |
|
ABCD3 |
ABCD3, PMP70, PXMP1: ATP-binding cassette sub-family D member 3 |
ABCD2 |
ABCD2, ALD1, ALDL1, ALDR, ALDRP: ATP-binding cassette sub-family D member 2 |
40.500 |
Evidence |
O
|